188 related articles for article (PubMed ID: 26146552)
1. Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes.
Wang Y; Li J; Chen Y; Oupický D
Biomater Sci; 2015 Jul; 3(7):1114-23. PubMed ID: 26146552
[TBL] [Abstract][Full Text] [Related]
2. Polymeric Plerixafor: effect of PEGylation on CXCR4 antagonism, cancer cell invasion, and DNA transfection.
Wang Y; Li J; Oupický D
Pharm Res; 2014 Dec; 31(12):3538-48. PubMed ID: 24942536
[TBL] [Abstract][Full Text] [Related]
3. Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor.
Li J; Oupický D
Biomaterials; 2014 Jul; 35(21):5572-9. PubMed ID: 24726746
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer.
Tang S; Hang Y; Ding L; Tang W; Yu A; Zhang C; Sil D; Xie Y; Oupický D
Mol Pharm; 2021 Dec; 18(12):4448-4458. PubMed ID: 34699242
[TBL] [Abstract][Full Text] [Related]
5. Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia.
Wang Y; Xie Y; Williams J; Hang Y; Richter L; Becker M; Amador C; Oupický D; Hyde RK
Cancer Gene Ther; 2020 Feb; 27(1-2):45-55. PubMed ID: 31028289
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.
Liu HM; Zhang YF; Xie YD; Cai YF; Li BY; Li W; Zeng LY; Li YL; Yu RT
Int J Nanomedicine; 2017; 12():1065-1083. PubMed ID: 28223799
[TBL] [Abstract][Full Text] [Related]
9. The modification of siRNA with 3' cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes.
Ambardekar VV; Han HY; Varney ML; Vinogradov SV; Singh RK; Vetro JA
Biomaterials; 2011 Feb; 32(5):1404-11. PubMed ID: 21047680
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1.
Benoit DS; Henry SM; Shubin AD; Hoffman AS; Stayton PS
Mol Pharm; 2010 Apr; 7(2):442-55. PubMed ID: 20073508
[TBL] [Abstract][Full Text] [Related]
11. Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer.
Hang Y; Tang S; Tang W; Větvička D; Zhang C; Xie Y; Yu F; Yu A; Sil D; Li J; Singh RK; Oupický D
J Control Release; 2021 May; 333():139-150. PubMed ID: 33774121
[TBL] [Abstract][Full Text] [Related]
12. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.
Sarett SM; Werfel TA; Chandra I; Jackson MA; Kavanaugh TE; Hattaway ME; Giorgio TD; Duvall CL
Biomaterials; 2016 Aug; 97():122-32. PubMed ID: 27163624
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X
J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.
Kim J; Kang Y; Tzeng SY; Green JJ
Acta Biomater; 2016 Sep; 41():293-301. PubMed ID: 27262740
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
17. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.
Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA
Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972
[TBL] [Abstract][Full Text] [Related]
18. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.
Xue J; Li R; Gao D; Chen F; Xie H
Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392
[TBL] [Abstract][Full Text] [Related]
19. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl
Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D
Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
Steele TW; Zhao X; Tarcha P; Kissel T
Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]